Molecular Devices Buys Xsira's Imaging Technology

The complete portfolio of Transfluor technology assets has been purchased from Xsira Pharmaceuticals for $11 million in cash by Molecular Devices, which makes bioanalytical tools. The technology, comprising proprietary assays that operate on imaging platforms such as Molecular Devices' Discovery-1 and ImageXpress systems, offers a way to visualize key cellular events and to detect receptor activation, according to Molecular of Sunnyvale, Calif.

Silicon Valley/San Jose Business Journal (http://sanjose.bizjournals.com/sanjose/stories/2005/03/07/daily31.html)